Speakers

BioInnovation Challenge

The BioInnovation Challenge is a two-part event. The eight semi-finalists will present their live pitches on November 3rd to our judges. On November 4th the three finalists will then present their live pitches again for a chance to win a $55,000 prize package. BioPort attendees will be given the opportunity to vote along with the judges to determine the winners.

 Judge – Arif Aziz, Senior Manager, National Life Science SR&ED, MNP

Arif Aziz Senior Manager, National Life Science SR&ED, MNPArifAziz is a Senior Manager leading MNP’s National Life Science SR&ED practice. Drawing on more than10 years of experience in assisting companies to obtain research funding to develop and commercialize new products and technologies, Arif helps clients understand the underlying research endeavor and how it relates to the SR&ED program and their business context to ensure clients realize maximally beneficial claims. He also helps organizations with general business strategy and commercialization of newly developed products and services in the life science sector. With deep knowledge and experience in SR&ED, business strategy, and commercialization Arif develops practical solutions and delivers results for his clients. His cross-industry expertise includes biotechnology, medical devices, pharmaceuticals, digital health, and professional services. Prior to starting his consulting career, he was a postdoctoral fellow at the Ottawa Hospital Research Institute.

Judge – Patricia Folkins, Partner, Bereskin & Parr LLP

Patricia Folkins is a partner with Bereskin & Parr LLP and Leader of the Chemical practice group. Her practice focuses on preparing and prosecuting patent applications in chemical, biotechnology, and pharmaceutical matters. She also assesses new technology and conducts portfolio management. Patricia completed a post-doctoral fellowship at Yale University before joining a leading biopharmaceutical company where she spent several years as a research scientist and then as a technical advisor in their patent department. She also previously worked at a prominent Canadian university as a Manager of Intellectual Property. Patricia is Chair of the Intellectual Property Institute of Canada’s (IPIC) PatentCommittee. She has co-authored several articles that have appeared in scientific journals including The Journal of Organic Chemistry, The Journal of Medicinal Chemistry, and Tetrahedron Letters. Patricia has also given presentations on intellectual property matters in general, and on issues specific to chemical and pharmaceutical patents.

Judge – Rhiannon Davies, Founding & Managing Partner, Sandpiper Ventures

Rhiannon is a Founding and Managing Partner at Sandpiper Ventures, an active investor and mentor for early-stage technology companies, and a strong supporter and advocates for female entrepreneurs. Rhiannon’s business leadership spans Europe, Asia, and South and North America. As Managing Director, she led the $2B revenue G.V.S.C. B.V. a subsidiary of GrandVision N.V. She also sat on the board of Directors that took GrandVision, a CAD $5.5 billion revenue retailer with businesses in 45countries, through 44% growth in SWS, expansion into 20 new markets through multiple acquisitions and organic growth, to a successful IPO on the ASE. The GrandVision IPO ranked in the global top tenIPOsin 2015. This was her second exit where she held equity ownership, following the acquisition of Royal Numico N.V. by Groupe Danone in 2007. Rhiannon serves/has served on multiple private and public companies and NGO boards. Rhiannon’s industry expertise spans medtech, CPG, retail, AI/ML, advanced manufacturing, and supply chain.

BIC Junior

Kicking off BioPort with our 3rd annual Health & Life Sciences youth pitch competition with partners Business is Jammin’ and Brilliant Labs and sponsored by MNP.

Judge – Kathleen Mitchell, Manager, Assurance and Business Advisory, MNP

Kathleen Mitchell is a Manager in MNP’s Assurance and Advisory practice. Kathleen delivers a full suite of assurance, accounting, and advisory services to clients across a variety of industries. She draws on her knowledge and skill to embrace the new and exciting challenges that her profession offers and helps to ensure clients are able to embrace new and exciting opportunities as they arise. Kathleen received her Bachelor of Commerce degree from Saint Mary’s University’s Sobey School of Business in 2012. Two years later, she became a Chartered Professional Accountant (CPA), qualifying as a Chartered Accountant (CA). Kathleen also holds the Certified Internal Auditor (CIA) designation. Kathleen is the Board Chair for the Centre of Entrepreneurship & Educational Development (CEED).

Judge – Sarah Upshaw, PLANS (Promoting Leadership in Health for African Nova Scotians) Program Manager, Dalhousie University

Sarah Upshaw is current the PLANS (Promoting Leadership in Health for African Nova Scotians) Program Manager at Dalhousie University. Sarah comes from a varied health background completing her Licensed Practical Nursing Program, a Bachelor of Science in Recreation from Dalhousie University, as well as a Master of Education in Counselling from Acadia University. Prior to her current role at Dalhousie Sarah worked in the field of Mental Health and Addiction services working with youth and adults in various roles. Sarah is from the Annapolis Valley and is passionate about creating awareness for rural youth of the opportunities available to them and is able to do that through her current role at Dalhousie. In her free time, Sarah enjoys spending time outside or near the water.

Judge – Alisha Collins, Creativity Catalyst, Brilliant Labs

Alisha is a designer and educator interested in integrating storytelling, craft, wellness, play, and new technologies to create participatory learning practices. Her practice centers on nurturing children’s creative confidence with new technologies and encouraging creative acts within their communities. She graduated from the MIT Media Lab, working closely with the Lifelong Kindergarten group. She has taught in diverse schools for twelve years, developing curriculums and leading PD workshops in India, the USA, Canada, and Brazil. She co-authored a book titled StartMaking!: A Guide to Engaging Young People in Maker Activities and co-founded the Duct Tape Network. She also started SEEDS, Science, Engineering, Esthetics, Design, and Storytelling, an interdisciplinary Studio Lab where youth can identify their creative self, develop a powerful vision, pursue a passion, creating an impact that matters in their worlds. Currently, she works with Brilliant Labs as Creativity Catalystand leads the Biomaking initiative.

Panels & Sessions

The Rise of Virtual Health Technologies in Canada

We are at the cusp of change in the way health services in Canada are delivered. Virtual health technologies bring transformational improvements in the affordability, accessibility, quality and sustainability of health care solutions. Join us to hear from industry leaders about the opportunities and benefits of virtual health technologies.

Dr. Gail Tomblin Murphy, Vice President of Research, Innovation & Discovery and Chief Nurse Executive, Nova Scotia Health

Dr. Gail Tomblin Murphy is the Vice President of Research, Innovation & Discovery, and Chief NurseExecutiveforNova Scotia Health. Gail is an active champion of research and innovation in healthcare, leading our teams to seek creative solutions and agile processes in order to deliver the best care for the best health outcomes. As an internationally recognized expert in population needs-based approaches to health systems and workforce planning, evaluation, and research, Gail has been an Expert Advisor on health workforce to the World Health Organization and Pan American Health Organization since 2005 and is the Director of the WHO/PAHO Collaborating Centre on Health Workforce Planning and Research (DalhousieUniversity).In May 2020, Gail was invited to join the National COVID-19 Immunity Task Force Leadership Group. She will be working with other scientific leaders from across Canada over the next two years to establish priorities and oversee the execution of a program of nation-wide serological studies. Gail completed her BN and MN degrees from Dalhousie University and her Ph.D. in nursing from theUniversity of Toronto. In 2019, she was inducted into the American Academy of Nursing as a Fellow.

Doug Samuelson Associate Director: Public Health, Policy, and External Affairs (Atlantic Canada), Merck Canada Inc.

Doug Samuelson is the Associate Director of Public Health, Policy, and External Affairs in the Atlantic region for Merck Canada Inc. He is a core member of Merck’s Virtual Care Network Team that has been assessing the virtual care and digital solutions landscape in Canada. Doug began his career with Merck in 2002 and has worked in several roles including, Sales, Training, Specialty Services, and Patient Access. Originally from Victoria, British Columbia, Doug holds a Bachelor of Science degree in biology from the University of Victoria and a Master of Business Administration degree in marketing and finance, from Dalhousie University.

Michael Green, President & CEO, Canada Health Infoway

Michael Green has an international reputation and a proven track record of transforming health care through the use of digital health. He has leveraged international research and innovation to advance the digital health agenda, create jobs, and stimulate economic growth in Canada. He was awarded theQueen Elizabeth II Diamond Jubilee Medal in 2012 for his contribution to the Canadian Health IT industry. Michael serves on the Board of Directors of Kids Help Phone and HIMSS North America. Heis a past Chair of the Information Technology Association of Canada (ITAC) Board of Directors and past director of the Medical Imaging & Technology Alliance (MITA—USA).

Supporting Greater Diversity & Inclusion in Canada’s Growing Health & Life Sciences Sector

More than ever, employers are prioritizing diversity and inclusion initiatives and investing resources into making sure they are building successful business environments. Join us for an insightful discussion with panelists who can speak to the strategies, policies, programs and initiatives that are needed to better support the advancement of diversity and inclusivity in Canada’s growing health and life sciences sector.

Moderator – Rob Henderson, President & CEO, BioTalent Canada

Rob Henderson, President and CEO of BioTalent Canada, is a seasoned executive with more than 25years of private and public sector management experience. He has transformed BioTalentCanada into an in-demand partner, policy influencer, and project leader that brings together the largest national bioeconomy network in Canada. Under Rob’s guidance, BioTalent Canada has engaged with government, employers, associations, post-secondary institutions, immigrant-serving agencies, and service providers. Together, this dynamic network strengthens skills, connects job-ready talent to the industry, and creates opportunities. Its proven performance provides the industry with funding, HR resources, and labour market intelligence to help companies successfully build their teams.

Colleen Belle, Facilitator, Workplace Culture, ISANS

The Workplace Culture Program at Immigrant Services of Nova Scotia (ISANS) is an employer-focused service dedicated to enhancing intercultural skills and increasing business success across Nova Scotia. Colleen Belle has been the Facilitator of the Workplace Culture Program at Immigrant ServicesAssociation of Nova Scotia (ISANS)since November 2019. She has worked as a Research Associate for The Executive Minds in Toronto where she provided strategies and training materials to advise university faculty, recruitment committees, and leaders on becoming more diverse and inclusive. She has also worked as a Communications Consultant for the World Ocean Council to enhance cross-cultural communication for their global reach. She has an MA with merit in Cross-Cultural Communication and International Relations from the UK; a BSc with honors in Management (Marketing) from the University of the West Indies in Barbados, where she also worked as a tutor; a Diploma in Early Childhood Education, with a Level 3 Classification; and an Associate Degree in Applied Arts.

Michael DeVenney, CFA, ICD.D, President, WorkInsights & Founder, The Mindset Project

Michael DeVenney has been working with entrepreneurs and leaders seeking growth since 2003. With his financial and strategy backgrounds, as well as positive psychology, he has expertise in the sustainable growth of organizations and leaders. He is an advocate for mental health and the LGBTQ+ community, having first-hand experience with discrimination on both sides. He has used this experience to fuel his work, having developed an analytic that measures the sentiment and influence at levels of the organization to provide key data and insights into creating an environment of true diversity, inclusion, and belonging. In 2015 he founded The Mindset Project to research and develop solutions centered on entrepreneurs, decision making, and overall wellness. More than eight published articles have highlighted the working environment for entrepreneurs and their teams to perform at their best. In 2017, following the development of outcomes from The Mindset Project, he founded WorkInsights to develop a business analytic tool to understand the working environment and the capacity for innovation, growth, and wellness. Michael is always learning to continue to add value to those he works with. His education includes: Disruptive Strategies diploma-Harvard Business School; Strategic Alignment certificate-OxfordUniversity’s Said School of Business; ICD.D designation-Institute for Corporate Directors and Rotman School of Business; Diploma in Applied Positive Psychology-Sir Wilfred Laurier University; diplomas in leadership, strategy, and organizational performance-Michigan State University, Notre Dame University, Villanova University, and the Center for Creative Leadership; diploma in investment return analysis-Villanova University; Chartered Financial Analyst designation and Fellowship-CanadianSecurities Industry; Bachelor of Business Administration-Acadia University

Carolann Wright, Director of Capacity Building & Strategic Initiatives, African Nova Scotian Communications, Halifax Partnership

Carolann is a trained facilitator and mediator with over 30 years of experience in the economic development sectors in Halifax, Toronto, South Africa, and now Ghana. She works with the African Nova Scotian community in the areas of strategic community and business planning and labour market development.

Building an Investment Ecosystem to Advance Health and Life Sciences in Atlantic Canada

There’s a strong and evolving health and life sciences sector developing in Atlantic Canada with exceptional companies in need of investors to help them grow and succeed. Investors play a critical role in the development of early-stage companies as they use those funds to innovate, accelerate and demonstrate value for future investors.

In this panel session, we will learn about effective activities, initiatives and strategies that will help to foster an investment landscape to support entrepreneurship and innovation – driving economic growth. Join us as we talk to industry leaders and policy makers about the opportunities and challenges of building an investment ecosystem to advance health and life sciences in Atlantic Canada.

Moderator – Tim Gillis, Former CEO, STI Technologies

Experienced in financial and executive management, strategic planning, process improvement, taxation, and mergers and acquisitions, Tim was the former CEO of STI Technologies. Prior to his CEO appointment in 2014, Tim served as CFO and VP of Operations. Tim steered STI Technologies through a period of dramatic growth culminated in the sale of the business to IQVIA (IQV:NYSE) in February 2017. The sale transaction was quoted in the press as one of Nova Scotia’s largest-ever tech exits. Tim was awarded Top 50 CEO in Atlantic Canada in 2016. STI Technologies was awarded Best Managed Companies in Canada in 2015 and 2016 and Deloitte’s North American Fast 50 Technology Companies in 2015. Before he joined STI Technologies in 2010, Tim held senior positions at a number of successful companies including Stantec, Ernst & Young, Clarke Inc., and Clear Picture Corporation. An active member of the community, Tim enjoys skiing, hiking, and mountain biking. Tim served on the Board of Directors of United Way Halifax for an approximate ten-year term. Currently, Tim serves on the Board of Eli Technologies, Next Leaf Solutions (CSE:OILS) and serves as an advisor to Blue Charm Adherence Inc. Tim holds a Bachelor of Commerce degree from Dalhousie University with distinction, a CA designation, and is a member of the Institute of Chartered Accountants of Nova Scotia.

Robin Phillips, Former Head of Global Investment and Corporate Banking, HSBC

Robin retired from HSBC at the end of July 2019 having been in charge of Global Banking-the Bank’s corporate and investment banking arm-since 2006. During this tenure, he spent 2011 to 2014 based in Hong Kong, where he was additionally responsible for the Asian markets business. Previous to HSBC, Robin occupied senior positions at Citigroup and UBS, and was globally responsible for the transportation and infrastructure investment banking business at Citigroup between 1999 and 2003. Today Robin is chairman of the foundation board of Pancreatic Cancer UK and Chairman of Affordable Infrastructure UK. He also sits on the mainboard of the International Airlines Group, the holding company for British Airways, Iberia, and Aer Lingus. In the US he acts as a senior advisor to Circadence corporation, the leading SaaS-based cybersecurity training group, and has recently joined the board of IR Scientific.

Ali Riaz, CEO & Chairman, OrbitMI Inc

As a business leader, entrepreneur, innovator and humanitarian at heart, Ali loves what he does. His true passion lies in being part of innovative, growth-oriented organizations and helps them achieve their full potential in the software and life sciences industries. As a CEO, he’s devoted his career to emerging businesses that are either small and poised for growth or needing turnaround, including architecting and delivering leading-edge strategies to enhance capabilities, driving customer focus, scaling operations and competing on a global scale. He’s founded a leading global unified information access platform company, creating an award-winning technology, raising $76M in the financing, becoming a preferred vendor for blue chip clients such as GE, Goldman, Citi, Fidelity, Cisco. He has also transformed an Enterprise Search Technology start up into a billion-dollar company, growing sales from $2M to $164M in five years, publicly listing the company, and orchestrating its sale to Microsoft for $1.2B. As a business advisor and board member, I’ve had the opportunity to help start up organizations enter the market and a global consultancy design and launch new digital service offerings. He’s formed, led and motivated worldwide teams comprised of more than 900 employees. I believe that it is critical to creating a transparent, trusting and teaming environment so people can share their ambitions, trust their instincts, solve issues, be the experts that they are, and innovate. His personal style is to blend confidence and humility, action and thought, and innovation and best practices. He applies a global perspective to life and works; he was raised in Norway, lived and worked in the USA, Switzerland and England, and established businesses everywhere from South Africa to Japan. Every day Ali tries to abide by these values: do the right thing, believe in people, have empathy, serve the community, have the courage to explore new paths, take responsibility and, most importantly, be grateful for this life.

Dr. Lidija Marusic, Investment Manager Life Sciences, Innovacorp

Dr. Lidija Marusic is an investment manager at Innovacorp, where her focus is on identifying attractive pre-seed and seed investment opportunities in the life sciences sectors. Joining Innovacorp in 2006, Lidija built the organization’s life sciences commercialization and venture capital practice. Today, in addition to managing a thriving portfolio of companies, Lidija fosters the commercialization of new medical innovations by guiding researchers and emerging start-up founders and helping deliver targeted acceleration programming. She manages all aspects of the investment review, approval and closing cycle, and works hands-on with Innovacorp’s portfolio companies to assist them in accelerating their growth, achieving milestones and securing additional financing. She also manages the organization’s Science and Technology Advisory Council. Lidija has extensive experience in the commercialization of life sciences technologies, along with a solid background in business, academic research, and innovation. Prior to joining Innovacorp, Lidija was an independent consultant providing technology assessment and business development services to the local life sciences industry. She was also previously an investment analyst with MedInnova Partners Inc., a seed fund focusing on commercializing biomedical discoveries. Lidija established MedInnova’s Halifax office, assessed investment opportunities, negotiated investment agreements, and worked with investees to develop R&D plans, manage intellectual property, and plan for the next stage of business growth. Concurrent to her work with MedInnova, Lidija was a lead investment analyst in neurosciences for MDS Capital Corp. (now Lumira Capital) in Toronto. She completed market, scientific and financial due diligence for MDS Capital investment groups related to investment opportunities typically in later stages of the commercialization cycle. Lidija holds a Doctor of Medicine degree from the University of Zagreb in Croatia, a Ph.D. in molecular genetics from the International School for Advanced Studies in Trieste, Italy, and an MBA from McMaster University in Hamilton, Ontario. Lidija served on the International Peer Review Panel for the Canadian Networks of Centres of Excellence (NCE) and on the Proof of Principle Peer Review Committee of the Canadian Institutes for Health Research (CIHR). She is also a board member at Covina Biomedical and DGI Clinical as well as at CVCA (Canadian Venture Capital and Private Equity Association), BioNova and BioTalent Canada. She is a board observer at Appili, Densitas and Spring Loaded Technology, and a member of the investment committee at MEDTEQ.

Keith MacIntyre, Partner, Grant Thornton LLP

Keith MacIntyre has significant expertise helping clients in technology, health, and life sciences deal with intricate matters of tax, with an emphasis on incentives for fundraising. As a partner of Grant Thornton LLP in Nova Scotia, Keith works to advance the interest of the investment community and support economic growth. He was one of the lead authors on a report, “Modernizing the Equity Tax Credit”, along with Scott Moffitt of BioNova, James Curry of ACOA, and Sean Sears of Ogden Pond Capital. The paper was co-presented by Grant Thornton, Cox & Palmer, and BioNova to the Province of Nova Scotia providing recommendations to evolve the equity tax credit to attract investment for Nova Scotia businesses. In addition to his advocacy efforts, Keith’s experience encompasses complex tax analysis, business structuring, strategic planning, transactions, and support for government incentives and grant programs. He assists clients thru the various stages of their business from start-up to growth to M&A, ensuring they reach their financial objectives. Keith is the former National leader of tax services for Grant Thornton in Canada.

Supporting Made in Canada Health Technology Manufacturing  

The COVID-19 pandemic highlighted the need for improved Canadian-based manufacturing of medical devices and other health related products. The shift in reliance on global suppliers has had many positive impacts for Canadian companies, our healthcare systems, the environment, and patients. Join us as industry leaders discuss the needs, requirements, capabilities, supports and opportunities for Canadian-based manufacturing of medical devices and other health related products.

Moderator – Scott Moffitt, Executive Director, BioNova

Scott is a senior management professional with more than 20 years of life science experience in the industry, government, and non-profit sectors. By leveraging his leadership and management abilities, Scott has built solid relationships and delivered significant results in each position he has held. Having returned to his home province a few years ago, Scott is now focused on making Nova Scotia a better place. Scott is presently the Executive Director of BioNova, Nova Scotia’s life sciences and biotechnology industry association and sector development organization, where he is leading the advancement of the sector for the Province of Nova Scotia to establish the life sciences as a pillar of the new economy. Scott leads a team focused on building collaborative relationships within the province and beyond to attract companies, investment, and people to Nova Scotia. Scott served most recently as the Senior Investment Officer-Bioscience, for Innovation PEI, the lead economic development agency for the Province of Prince Edward Island. In this position, Scott led a team of professionals and was responsible for the growth of the bioscience sector through prospecting, attracting, and investing in international businesses, and by internal business growth of on-island companies. Among his significant previous positions, Scott was the commercialization officer with BioNova, assisting early-stage companies with their business development efforts, offering strategic business and industry advice to accelerate commercial development and build value. Prior to this, Scott served as the marketing manager for the microbiology division of Thermo Fisher Scientific, where he was responsible for overall market development, the introduction of innovative strategies, and the management of supplier partners for the Canadian marketplace. Scott has a Bachelor and Master of Science degrees from Acadia University and presently resides in Halifax, NS with his family.

Patrick Sullivan, President &CEO, Halifax Chamber of Commerce

Mr. Sullivan is the CEO of the Halifax Chamber of Commerce and has over 30 years of marketing and general management experience. Mr. Sullivan began his career at Procter and Gamble in Toronto and held progressive marketing positions in Toronto, Halifax, as well as domestic and international markets. He has been General Manager and President for both start-up and large organizations, including Indigo.ca and Workopolis.com. Most recently Mr. Sullivan was the CEO of the Nova Scotia Tourism Agency. He enjoys running and has run half-marathons, marathons, and in October of 2011, completed a 250km run across the Sahara Desert. He holds a Bachelor of Business Administration from Mount Saint Vincent University.

Cathy Bennett, Founder & Board Chair of TaskForceNL

As a former CEO, seasoned entrepreneur, current board director, and consultant, Cathy’s focus is growth. With over 30 years of business leadership, her own company Bennett Group of Companies grew from a small group of service businesses to operations in commercial and industrial construction, industrial manufacturing, human resource support, service, retail, industrial supply, and real estate investments and operations. She serves and has served, on numerous privately-held corporate boards with interests in real estate, natural resources, manufacturing, industrial construction, technology, and business services. She is currently a Director with Vigilant Management, Kraken Robotics, and the Business Development Bank of Canada, as well as SheEO.Over her career, she has been an active board member of dozens of community-based organizations including the St. John’s Board of Trade and the Canadian Chamber of Commerce. In addition to her work on the board of Propel–Atlantic Canada’s e-accelerator for tech start-ups–she is the founder and co-chair of ConnectioNL, a community-based volunteer organization facilitating mentorship for growing start-up businesses. She is a co-founder and Managing Partner of Sandpiper Venturesandassociate fellow with the Creative Destruction Lab. She has served as a Member of the Newfoundland & Labrador House of Assembly serving in Cabinet as Minister of Finance, Minister Responsible for the Status of Women, and the Office of the Chief Information Officer. Currently, Cathy is the founder & Board Chair of TaskForceNL, a social enterprise initially to support PPE manufacturing during the COVID-19 pandemic, with 5 products currently approved by Health Canada and several in the development stage.

Brian Lewis, President & CEO, Medtech Canada

Brian Lewis is the President & CEO of Medtech Canada, the Canadian association representing the medical technology industry and diagnostic companies across Canada. Prior to joining in 2012, Brian worked for Genzyme Canada from May 2005 until December 2012 as General Manager, where he was responsible for strategic direction and operations. He brought extensive leadership experience to Genzyme, having held progressive management positions at Hoechst Marion Roussel, Serono, and AstraZeneca Canada. Mr. Lewis has a Bachelor of Science in Human Kinetics from the University of Guelph and a Bachelor of Business Administration from York University.

Brian Jeffers, President & CEO, BioMedica Diagnostics

Brian has over 25 years of creating and fostering successful, collaborative internal, and external stakeholder relationships in the pharmaceutical and medical device industries. He is a focused leader driven to exceed results and partner expectations, while demonstrating every day the true meaning of a team player.

The Adoption and Integration of Health Technologies in Canada

In this session, we will be taking a deeper dive into what it takes to integrate health technologies into our healthcare systems. Join us to hear from Nova Scotia Health and industry leaders about the planning and challenges of adopting and integrating health technologies and what is being done in Nova Scotia to lead in this area.

We will cover a number of areas, including the value of innovative products, mechanisms to integrate within healthcare, understanding healthcare’s needs, benefits to patients and the economic upside of utilizing health infrastructure for research, development and commercialization.

Moderator – Paul Bradley, President, MedTech Consulting

Paul Bradley is a healthcare industry executive holding leadership roles in many functional areas at Johnson & Johnson including sales, marketing, strategic account management, human resources, and operations. In his final years at Johnston & Johnson Paul lead the strategic affairs team which included health economics and market access, professional education, clinical and regulatory affairs, quality, and was a member of the J&J Management Board. In 2016 Paul retired from Johnson & Johnson, creating MedTech Consulting where he works with medical technology startups, scale-ups, global companies, and various supporting organizations that focus on advancing the medical technology market. Paul is also a leader within the Canadian medical technology industry, with contributions from various Board positions. Paul is currently Board Chair of ventureLAB, a member of the Ontario Health Technology Committee (OHTAC), and a Board member of DeCell Technologies, a medical technology company in Halifax. Paul also served on the Medtech Canada Board from 2009 to 2016 and was Board Chair for his final three years.

Jeff Mullen, CPA, CA, Director, Enterprise Development, Atlantic Canada Opportunities Agency (ACOA)

Jeff Mullen has worked with Atlantic Canadian businesses for over 30 years. He began his career as a Chartered Accountant with Coopers & Lybrand and joined the Atlantic Canadian Opportunities Agency (ACOA) in 1993. Jeff has worked with businesses from a range of sectors including manufacturing, ocean technology, ICT, and resource industries, helping them to establish, expand, and improve productivity and profit margins. Jeff has been the Director of Enterprise Development for ACOA Nova Scotia since 2005 and, along with his team, manages an annual program budget in excess of $50M.

Doris Grant, Senior Director, Innovation, Nova Scotia Health

Doris Grant is the Senior Director of Innovation at Nova Scotia Health where she leads a team focused on transforming the health and health care of Nova Scotians through innovation-driven solutions and opportunities. She brings over 20years of experience delivering impactful research and commercial partnerships with industry, entrepreneurs, government, researchers, and clinicians. Most recently, Doris led both the commercialization and industry engagement activities for the life and health science sectors at DalhousieUniversity’s Industry Liaison and Innovation office. Here she played a pivotal role in transferring technologies from the bench to the marketplace and establishing key industry research collaborations having significant societal and economic impacts. Prior to Dalhousie, Doris spent several years in business development and the intellectual property departments at a large US-based pharmaceutical company. Doris is a proud Aggie having obtained her B.Sc. and M.Sc. from the Nova Scotia Agricultural College/Dalhousie University.

Alastair ‘Alf’ Trower, Director of Business Development, Enginuity Inc.

In 2013, Alastair ‘Alf’ Trowerhadthe fortune to meet Ben Garvey, owner of the local engineering firm Enginuity, hitting it off and possessing skills needed by the business to start an aggressive growth period-focused on solving complex engineering problems for the industrial sector in the Maritimes, designing new products for entrepreneurs, and commercializing their own ideas. Ideas that include a Class 1 medical device start-up, FIVA-MedInc, with Dr.Orlando Hung in Halifax. Enginuity is quickly becoming a local powerhouse, employing graduates, attracting out of region talent, and helping businesses remain competitive through automation and robotics. Enginuity has just been named a Finalist in the Halifax Chamber Business Awards most Innovative Business category.

Margaret Palmeter, Founding Director, Emera ideaHUB

Margaret Palmeter is the Founding Director of Dalhousie University’s Emera ideaHUB. She comes to this role from Dalhousie Industry Liaison & Innovation (ILI), where she managed a patent portfolio and commercialized technologies on behalf of the University and Researchers. Her IP portfolio included medical-device technologies and mechanical assemblies in multiple industry sectors. She brings this experience and knowledge to her role with the Emera ideaHUB and supports teams and startups in accessing the resources needed to get their company and technology through the prototyping phase and ready for market. The Emera ideaHUB is Atlantic Canada’s leading hardware incubator for early-stage deep technology companies.

Scott Moffitt, Executive Director, BioNova

Scott is a senior management professional with more than 20 years of life science experience in the industry, government, and non-profit sectors. By leveraging his leadership and management abilities, Scott has built solid relationships and delivered significant results in each position he has held. Having returned to his home province a few years ago, Scott is now focused on making Nova Scotia a better place. Scott is presently the Executive Director of BioNova, Nova Scotia’s life sciences and biotechnology industry association and sector development organization, where he is leading the advancement of the sector for the Province of Nova Scotia to establish the life sciences as a pillar of the new economy. Scott leads a team focused on building collaborative relationships within the province and beyond to attract companies, investment, and people to Nova Scotia. Scott served most recently as the Senior Investment Officer-Bioscience, for Innovation PEI, the lead economic development agency for the Province of Prince Edward Island. In this position, Scott led a team of professionals and was responsible for the growth of the bioscience sector through prospecting, attracting, and investing in international businesses, and by internal business growth of on-island companies. Among his significant previous positions, Scott was the commercialization officer with BioNova, assisting early-stage companies with their business development efforts, offering strategic business and industry advice to accelerate commercial development and build value. Prior to this, Scott served as the marketing manager for the microbiology division of Thermo Fisher Scientific, where he was responsible for overall market development, the introduction of innovative strategies, and the management of supplier partners for the Canadian marketplace. Scott has a Bachelor and Master of Science degrees from Acadia University and presently resides in Halifax, NS with his family.